Related Experiment Videos
Low-dose zinc administration as an effective Wilson's disease treatment
J Najda1, B Stella-Hołowiecka, M Machalski
1Clinical Department of Internal Diseases and Oncological Chemotherapy, Silesian Medical Academy, Katowice, Poland.
Abstract:
A case of a 11-yr-long Wilson's disease treatment in a 16-yr-old boy with neurologic presentation was analyzed and monitored. In the face of severe symptoms of chelator intolerance, a comparatively low dose of 100 mg of zinc has been administered for the entire 11-yr-long treatment. Considerable improvement of clinical status was achieved, with accompanying regression of central nervous system lesion. The parameters of copper metabolism were normalized with effective urine elimination. The low-dose oral zinc intake proved to be therapeutically effective, eliminating further copper tissue toxicity.